These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 2441731

  • 1. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P, Haglund C, Roberts PJ, Jalanko H.
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
    Haglund C.
    Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
    Andriulli A, Gindro T, Piantino P, Farini R, Cavallini G, Piazzi L, Naccarato R, Dobrilla G, Verme G, Scuro LA.
    Digestion; 1986 Dec; 33(1):26-33. PubMed ID: 3940235
    [Abstract] [Full Text] [Related]

  • 6. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH, Eberl W, Kreiker C, Kalthoff H, Bützow GH, Jessen K, Klapdor R, Soehendra N, Wargenau M, Classen M.
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [Abstract] [Full Text] [Related]

  • 7. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
    Yoshikawa T, Nishida K, Tanigawa M, Fukumoto K, Kondo M.
    Digestion; 1985 Jun; 31(2-3):67-76. PubMed ID: 2581838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
    Heptner G, Domschke S, Domschke W.
    Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumour marker CA 125 in patients with digestive tract malignancies.
    Haglund C, Kuusela P, Roberts P, Jalanko H.
    Scand J Clin Lab Invest; 1991 May; 51(3):265-270. PubMed ID: 1715601
    [Abstract] [Full Text] [Related]

  • 12. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A, Kessler AC.
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [Abstract] [Full Text] [Related]

  • 13. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G, Piantino P, Cerchier A, Pecchio F.
    Minerva Med; 1985 Apr 14; 76(16):765-70. PubMed ID: 2582313
    [Abstract] [Full Text] [Related]

  • 14. Tumour markers in pancreatic cancer.
    Haglund C, Roberts PJ, Kuusela P, Jalanko H.
    Scand J Gastroenterol Suppl; 1986 Apr 14; 126():75-8. PubMed ID: 3470921
    [Abstract] [Full Text] [Related]

  • 15. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ.
    Acta Gastroenterol Belg; 1987 Apr 14; 50(1):29-35. PubMed ID: 3480668
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA.
    Civardi G, Cerri L, Cavanna L, Fornari F, Di Stasi M, Binelli F.
    Tumori; 1986 Dec 31; 72(6):621-4. PubMed ID: 3468674
    [Abstract] [Full Text] [Related]

  • 18. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C.
    Anticancer Res; 2002 Dec 31; 22(4):2311-6. PubMed ID: 12174919
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum levels of carcinoembryonic antigen, gastrointestinal cancer-associated antigen and alphafetoprotein in staging and management of patients with advanced carcinoma of the stomach.
    Szymendera JJ, Szawlowski AW, Nowacki MP, Kowalska M, Kaminska JA, Kozlowicz-Gudzinska I.
    Int J Biol Markers; 1987 Dec 31; 2(1):19-24. PubMed ID: 2448400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.